Compound ID | 2835
Class: Oxazolidinone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Neisseria gonorrhoeae |
| Description: | Compound discovered from the Medicine for Malaria Venture (MMV) Pathogen Box |
| Institute where first reported: | University of Pretoria, Pretoria, South Africa |
| Year first mentioned: | 2023 |
| Development status: | Experimental |